Search

everythinglearnresearchcommunity

for

Search:↓

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Hesperidin protects rat testicles from finasteride damage and improves sperm health.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

DA-9401 helps protect rat testis from finasteride damage.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Overexpression of hurpin in mice leads to abnormal skin and higher skin cancer risk.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Diphenylcyclopropenone's effectiveness and safety for alopecia areata are unclear.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Letrozole may help prevent seizures by reducing certain hormone levels.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Tofacitinib helped a woman regrow hair with no major side effects.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.